Related Experiment Video
Updated: Jun 17, 2026

Spheroid Assay to Measure TGF-β-induced Invasion
Published on: November 16, 2011
Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-beta-mediated cancer cell invasiveness
Isao Matsuura1, Chen-Yu Lai, Keng-Nan Chiang
1Division of Molecular and Genomic Medicine, National Health Research Institutes, 35 Keyan Road, Zhunan, Miaoli County 35053, Taiwan. imatsuura@nhri.org.tw
Abstract:
TGF-beta (transforming growth factor-beta) induces a cytostatic response in most normal cell types. In cancer cells, however, it often promotes metastasis, and its high expression is correlated with poor prognosis. In the present study, we show that S100A4, a metastasis-associated protein, also called metastatin-1, can physically and functionally interact with Smad3, an important mediator of TGF-beta signalling. In agreement with its known property, S100A4 binds to Smad3 in a Ca2+-dependent manner. The S100A4-binding site is located in the N-terminal region of Smad3. S100A4 can potentiate transcriptional activity of Smad3 and the related Smad2. When exogenously expressed in MCF10CA1a.cl1, an MCF10-derived breast cancer cell line, S100A4 increases TGF-beta-induced MMP-9 (matrix metalloproteinase-9) expression. On the other hand, depletion of S100A4 by siRNA (small interfering RNA) from the MDA-MB231 cell line results in attenuation of MMP-9 induction by TGF-beta. Consistent with these observations, S100A4 increases cell invasion ability induced by TGF-beta in MCF10CA1a.cl1 cells, and depletion of the protein in MDA-MB-231 cells inhibits it. Because expression of both S100A4 and TGF-beta is highly elevated in many types of malignant tumours, S100A4 and Smad3 may co-operatively increase metastatic activity of some types of cancer cells.
Insights
S100A4 protein physically interacts with Smad3, enhancing transforming growth factor-beta (TGF-beta) signaling. This interaction promotes cancer cell metastasis and matrix metalloproteinase-9 expression, suggesting a co-operative role in malignant tumor progression.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Transforming growth factor-beta (TGF-beta) typically causes cytostasis in normal cells but promotes metastasis in cancer.
- High TGF-beta expression correlates with poor prognosis in various cancers.
- S100A4, a metastasis-associated protein, is implicated in cancer progression.
Purpose of the Study:
- To investigate the interaction between S100A4 and Smad3, a key mediator of TGF-beta signaling.
- To determine the functional consequences of this interaction on TGF-beta-induced gene expression and cell invasion.
- To elucidate the role of S100A4 in TGF-beta-driven cancer metastasis.
Main Methods:
- Co-immunoprecipitation assays to demonstrate physical interaction between S100A4 and Smad3.
- Calcium-dependent binding assays.
- Reporter gene assays to assess transcriptional activity.
- Small interfering RNA (siRNA) mediated depletion of S100A4.
- In vitro cell invasion assays.
Main Results:
- S100A4 physically and functionally interacts with Smad3 in a calcium-dependent manner.
- S100A4 potentiates the transcriptional activity of Smad3 and Smad2.
- S100A4 enhances TGF-beta-induced matrix metalloproteinase-9 (MMP-9) expression and cell invasion.
- Depletion of S100A4 attenuates TGF-beta-induced MMP-9 expression and invasion.
Conclusions:
- S100A4 interacts with Smad3, enhancing TGF-beta signaling pathways.
- S100A4 promotes cancer cell invasion and metastasis by potentiating TGF-beta effects.
- S100A4 and TGF-beta may co-operatively drive metastatic activity in malignant tumors.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Cancer Cell Migration through Invadopodia
Intracellular Signaling Affects Focal Adhesions
Some...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
Mitogens and the Cell Cycle

